Moleculin Biotech
| Region | Nordamerika |
| ISIN | US60855D1019 |
| Sektor | Biotechnologie |
| Website | http://www.moleculin.com/ |
Moleculin Biotech is preclinical and clinical-stage pharmaceutical company focused on the development of game-changing anti-cancer drug candidates, many of which are based on discoveries made at M.D. Anderson Cancer Center, the world’s largest cancer research facility headquartered within the world’s largest medical center.
| Titel | Datum |
|---|---|
| MISC adds two LNG dual-fuel Suezmax vessels to its fleet | vor 20 Tagen |
| MISC Unveils Two New LNG Carriers For QatarEnergy Expansion | vor ungefähr 2 Monaten |
| Stock Picks: MISC And United Plantations | vor ungefähr 2 Monaten |
| MISC Commits RM40 Million to Develop Malaysia's Maritime Talent | vor ungefähr 2 Monaten |
| Latest Tanker Adds Another Growth Opportunity For MISC | vor ungefähr 3 Monaten |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Minori Solutions (1 Artikel) | |
| Microsoft (1 Artikel) | |
| Moovly Media (1 Artikel) | |
| MorphoSys (1 Artikel) | |
| Alle anzeigen | |